Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.97M Buy
84,000
+42,500
+102% +$1.73M 0.04% 600
2025
Q4
$1.69M Buy
41,500
+12,330
+42% +$536K 0.03% 751
2025
Q3
$1.37M Buy
+29,170
New +$1.51M 0.02% 780
2024
Q3
Sell
-14,523
Closed -$1.01M 1252
2024
Q2
$1.01M Sell
14,523
-27,027
-65% -$1.97M 0.03% 682
2024
Q1
$3.33M Buy
+41,550
New +$3.7M 0.13% 264

Other funds holding CNMD

Algert Global's CNMD Position: Q1 2026 in Review

Algert Global increased its CONMED (CNMD) stake by 102% in Q1 2026, buying an estimated $1.73M and bringing the position to 84,000 shares worth $2.97M. The position accounts for 0.04% of the portfolio, ranked #600.

Algert Global first reported a position in CNMD in Q1 2024 and has held it in 5 quarters since. The position peaked at $3.33M in Q1 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Algert Global held 84,000 shares of CONMED worth $2.97M as of Q1 2026.
  • Algert Global bought 42,500 CONMED shares in Q1 2026, an estimated $1.73M.
  • CONMED made up 0.04% of Algert Global's portfolio in Q1 2026, its #600 holding.
  • Algert Global first reported a position in CONMED in Q1 2024 and has held it in 5 quarters since.
  • Algert Global's CONMED position peaked at $3.33M in Q1 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.